steroid resistant nephrotic syndrome in childhood: Single-centre experience


Cite item

Full Text

Abstract

Aim. Assessment of survival of children with steroid-resistant nephrotic syndrome in Ukraine, determination of risk factors for chronic renal failure development.
Methods. Clinical evolution of 646 children with steroid-resistant nephrotic syndrome was performed according to the hospitalization periods (1980 - 2000 and 2001 - 2006).
Results Clinical and morphological dynamics of steroid-resistant nephrotic syndrome in children was detected. In 1980 - 2000 the main risk factors for chronic renal failure development were renal function deterioration in the debut of the diasease and arterial hypertension. In 2001-2006 cumulative risk of chronic renal failure decreased (27,7% vs 39,7% in 1980-2000, p=0,008). In 2001-2006 risk of chronic heart failure became higher in boys aged 3 - 6 years.
Conclusion. Dynamics of clinical and moprphological characteristics and chronic renal failure risk in children with chronic renal failure call for immunosuppressive therapy protocols optimization

References

  1. Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J. Paediatr. Child Health. 2007; 4: 337-341.
  2. Kim J.S., Bellew C.A., Silverstein D.M. et al. High incidence of initial and late steroid resistance in childhood nephrotic syndrome. Kidney Int. 2005; 68: 1275-1281.
  3. Mekahli D. A. Liutkus, B. Ranchin et al. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: a multicenter study. Pediatr. Nephrol. 2009. Режим доступа: doi: 10.1007/s00467-009-1138-5.
  4. Avner E.D., Harmon W.E., Niaudet P. Pediatric nephrology. Philadelphia: Lippincott Williams & Wilkins. 2004. 543-573.
  5. Eddy A.A., Symons J.M. Nephrotic syndrome in childhood. Lancet. 2003; 362: 629-639.
  6. Tarshish P., Tobin J.N., Bernstein J. et al. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J. Am. Soc. Nephrol. 1997; 8: 769-776.
  7. Tune B.M., Mendoza S.A. Treatment of idiopathic nephrоtic syndrome: regimens and outcomes in children and adults. J. Am. Soc. Nephrol. 1997; 8: P. 824-832.
  8. Hodson E.M., Habashy D., Craig J.C. Interventions for idiopathic steroid-resistant nephrotic syndrome in children. Cochrane Database Syst. Rev. (2): CD003594. 2006. Режим доступа: doi: 10.1002/14651858.CD003594.pub3.
  9. Hodson E.M., Willis N.S., Craig J.C. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database Syst. Rev. (1): CD002290. 2008. Режим доступа: doi: 10.1002/14651858.CD002290.pub3.
  10. Ehrich J.H.H. Geerlings C., Zivicnjak M., et al. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol. Dial. Transplant. 2007; 22: 2183-2193.
  11. Coppo R. Non-steroidal and non-cytotoxic therapies for nephrotic syndrome. Nephrol. Dial. Transplant. 2008; 1-3. Режим доступа: doi: 10.1093/ndt/gfn211.
  12. Цыгин А.Н., Комарова О.В., Сергеева Т.В. и др. Нефротический синдром. В: Баранов А.А. (ред) Клинические рекомендации по педиатрии. М : Геотар-Медиас. 2005. 107-128.
  13. Gipson D.S., Chin H., Presler T.P. et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr. Nephrol. 2006; 21: 344-349.
  14. Martinelli R., Okumura A.S., Pereira L.J. et al. Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr. Nephrol. 2001; 16: 658-661.
  15. Abrantes M.M., Cardoso L.S.B., Lima E.M. et al. Predictive factors of chronic kidney disease in primary focal segmental glomerulosclerosis. Pediatr. Nephrol. 2006; 21: 1003-1012.
  16. K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am. J. Kidney Disease 2002; 39: 1-266.
  17. Багдасарова И.В., Фомина С.П. Диагностика и лечение нефротического синдрома у детей. Современная педиатрия 2005; 1 (6): 154-158.
  18. Fomina S., Bagdasarova I. Outcomes of glucocorticoid therapy in the children with steroid sensitive and steroid resistance nephrotic syndrome. WCN2009 Su754. 2009 May; [cited 2009 May 24]. Режим доступа: <http://www.postersessiononline>.eu/aula_poster.asp
  19. Фомина С.П., Багдасарова И.В. Иммуносупрессивная терапия гормонорезистентного нефротического синдрома у детей: алкилирующие агенты. Укр. журнал нефрології та діалізу 2010; 1 (25): 27-33.
  20. Fomina S., Bagdasarova I. Efficiency of Cyclosporin A and Mycophenolate Mofetil in the children with steroid sensitive nephrotic syndrome. WCN2009 Su732. 2009 May; [cited 2009 May 24]. Режим доступa: http://www.postersessiononline.eu/aula_poster.asp
  21. Rice J.A. Mathematical Statistics and Data Analysis. Duxbury Press. 2006. 348-353.
  22. Paik K.H., Lee B.H., Cho H.Y. et al. Primary focal segmental glomerular sclerosis in children: clinical course and prognosis. Pediatr. Nephrol. 2007; 22: 389-395.
  23. Chesney R. The changing face of childhood nephrotic syndrome. Kidney Int. 2004; 66: 1294-1302.
  24. Borges F.F., Shiraichi L., da Silva M.P. et al. Is focal segmental glomerulosclerosis increasing in patients with nephrotic syndrome? Pediatr. Nephrol. 2007; 22: 1309-1313.
  25. Abeyagunawardena A.S., Sebire N.J., Risdon R.A. et al. Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr. Nephrol. 2007; 22: 215-221.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies